Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RESPOND: Re-positionable Lotus Valve System - Post Market Evaluation of Real World Clinical Outcomes

NCT02031302 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT02031302
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02031302 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RESPOND: Re-positionable Lotus Valve System - Post Market Evaluation of Real World Clinical Outcomes
Lead sponsor
Boston Scientific Corporation
Phase
Observational
Overall status
Completed
Start date
May 27, 2014
Completion date
May 18, 2021
Enrollment
1,064 (actual)
Sites
41

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve stenosis